Percutaneous coronary intervention for left main artery disease in patients with acute coronary syndrome
Study of Percutaneous Coronary Intervention in Left Main Coronary Artery Disease in Patients With Acute Coronary Syndrome at Sohag University Hospitals
This study tests if a procedure called percutaneous coronary intervention can help patients with acute coronary syndrome and left main artery disease feel better and improve their heart health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Sohag University Academic / other |
| Locations | 1 site (Sohag) |
| Trial ID | NCT06328322 on ClinicalTrials.gov |
What this trial studies
This study focuses on patients suffering from acute coronary syndromes (ACS) who have left main coronary artery disease (LMCAD). It aims to evaluate the effectiveness of percutaneous coronary intervention (PCI) as a treatment strategy for this condition. The study will observe the outcomes of patients undergoing PCI at Sohag University Hospitals, emphasizing the management of LMCAD associated with ACS. The research seeks to address the clinical challenges posed by this serious cardiovascular condition.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old diagnosed with acute coronary syndromes and left main coronary artery disease.
Not a fit: Patients with severe comorbidities, prior history of PCI with left main stenting, or contraindications to the procedures may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve treatment outcomes for patients with left main coronary artery disease and acute coronary syndrome.
How similar studies have performed: While there have been studies on PCI for coronary artery disease, the specific focus on left main artery disease in the context of acute coronary syndrome is less common, making this approach somewhat novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 years. * Acute coronary syndromes (ACS). * Left main coronary artery disease (LMCAD) on CA. Exclusion Criteria: * Patients with contraindications to coronary angiography or invasive procedures. * Prior history of percutaneous coronary intervention (PCI) with left main stenting. * Known allergy or intolerance to the medications or devices commonly used during PCI procedures. * Severe comorbidities or conditions that may limit life expectancy or impact the ability to follow the study protocol. * Pregnancy or lactation. * Refusal to participate * Contra indication to antiplatelet.
Where this trial is running
Sohag
- Sohag university Hospital — Sohag, Egypt (Recruiting)
Study contacts
- Study coordinator: Mohammed M Bahaa Eldeen, assistant lecutrer
- Email: mohamed.mohamed6@med.sohag.edu.eg
- Phone: 01023620185
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.